jim cramer: there will be push back on biogen's alzheimer's drug price
Published 3 years ago • 4K plays • Length 1:50Download video MP4
Download video MP3
Similar videos
-
9:36
consumers are demanding bargains, says jim cramer
-
3:32
jim cramer on how lilly's alzheimer's drug compares to biogen's
-
3:45
cramer: biogen's alzheimer's treatment would be 'the biggest drug ever'
-
2:12
jim cramer on fda resignations connected to the approval of biogen’s alzheimer’s drug
-
2:02
jim cramer explains why eli lilly will be the winner over biogen in alzheimer's fight
-
3:09
now is the time for investors to take profits in biogen, says jim cramer
-
3:17
jim cramer looks at where consumers are rebelling against higher prices
-
4:19
why this analyst remains a 'skeptic' on biogen's new alzheimer's drug
-
3:01
potential breakthrough: new treatment for alzheimer's
-
10:54
flags burned, monuments graffitied and us flags replaced with palestinian ones by protesters
-
10:50
jim cramer talks today's mega-cap meltdown
-
2:56
biogen shares spike after fda approves alzheimer's drug
-
3:51
breaking down the costs of biogen's billion-dollar alzheimer's drug
-
1:31
alzheimer's drug decision day: fda to decide on biogen and eisai treatments
-
4:21
biogen soars on promising results from alzheimer's drug trial
-
2:44
jim cramer on how eli lilly could be impacted by mixed alzheimer's drug study results
-
2:41
analyst on what biogen's alzheimer's drug means for the company
-
5:04
this analyst breaks down the bull case for biogen's alzheimer's drug
-
3:51
lightning round: sap is not done going higher, says jim cramer
-
5:19
analyst: it's unclear whether biogen's new alzheimer's drug will get approved
-
4:05
biogen shares surge on upbeat alzheimer's study results
-
11:19
lightning will never 'strike' an index fund like it did biogen on tuesday, jim cramer says